A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study

Type of Cancer
Lymphoma

Phase

Division (Location)

Study ID

NCT#

Brief Description
A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.